Kbc Group Nv Zynex Inc Transaction History

Kbc Group Nv

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Feb 15, 2024	SELL	$8.59 - $14.56 $10,574 - $17,923	-1,231 Reduced 48.16%	1,325 $13,000
Q2 2023 Jul 28, 2023	SELL	$8.59 - $14.56 $10,574 - $17,923	-1,231 Reduced 48.16%	1,325 $13,000
Q3 2022 Feb 15, 2024	BUY	$7.19 - $9.91 $18,377 - $25,329	2,556 New	2,556 $23,000
Q2 2022 Feb 14, 2024	BUY	$5.78 - $8.87 $14,773 - $22,671	2,556 New	2,556 $20,000
Q2 2022 Jul 26, 2022	BUY	$5.78 - $8.87 $14,773 - $22,671	2,556 New	2,556 $20,000

103

8.4M

200

1.5K

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $315M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.